Thymogen
Typical Dosage
Intranasal: 50 mcg
Injection: 500-100 mcg
Administration
Nasal • Intramuscular Injection
Half-Life
Short (dipeptide)
Mechanism of Action
Immune modulation|T-cell function support|Mucosal immunity studies|Recovery protocols
Research Protocol Summary
Evidence Level
Clinical Use / Mixed Literature
Typical Protocol Duration
3-20 days
Species Studied
Human • Mouse • Rat
Administration Schedule
2 Times A Day Intranasal/1 Time Daily Injection
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…